FDA's Woodcock on New Unit to Boost Drug Oversight

Feb. 14 (Bloomberg) -- Janet Woodcock, director of the U.S. Food and Drug Administration's Center for Drug Evaluation and Research, speaks about the agency's decision to form a new unit to improve the FDA's scrutiny of brand-name, generic and over-the-counter drugs. Woodcock speaks at the Bloomberg 2014 State of Health Care summit in New York. (Source: Bloomberg)
Global Markets: Strategies for the Long Trends
35:06 - Coutts & Co Global Chief Economist Mark McFarland discusses the key data that could move markets this week and what investors should be doing. He speaks to Bloomberg's Rishaad Salamat on "Trending Business." (Source: Bloomberg)
  • China Banks to Have 'Negative' Growth: Mizuho's Antos
  • Investing In Asia's Future Female Leaders
  • Why Investors Say Malaysia Is Still a Good Option